Abstract
A phase I/II study of the combination of indoximod and temozolomide for adult patients with temozolomide-refractory primary malignant brain tumors
Journal of clinical oncology, Vol.32(15_suppl), pp.TPS2107-TPS2107
05/20/2014
DOI: 10.1200/jco.2014.32.15_suppl.tps2107
Abstract
Abstract only
Details
- Title: Subtitle
- A phase I/II study of the combination of indoximod and temozolomide for adult patients with temozolomide-refractory primary malignant brain tumors
- Creators
- Yousef Zakharia - Georgia Regents Medical CenterTheodore S. Johnson - Georgia Regents Medical CenterHoward Colman - Huntsman Cancer InstituteNicholas N. Vahanian - NewLink GeneticsCharles J. Link - NewLink GeneticsEugene Kennedy - NewLink GeneticsRamses F. Sadek - Augusta UniversityFeng Ming Kong - Georgia Regents Medical CenterJohn Vender - Georgia Regents Medical CenterDavid Munn - Georgia Regents Medical CenterOlivier Rixe - Georgia Regents Medical Center
- Resource Type
- Abstract
- Publication Details
- Journal of clinical oncology, Vol.32(15_suppl), pp.TPS2107-TPS2107
- DOI
- 10.1200/jco.2014.32.15_suppl.tps2107
- ISSN
- 0732-183X
- eISSN
- 1527-7755
- Language
- English
- Date published
- 05/20/2014
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9984548378002771
Metrics
2 Record Views